Low bone mass and high material bone density in two patients with Loeys-Dietz syndrome caused by transforming growth factor beta receptor 2 mutations - PubMed

Affiliations

• PMID: 22095581
• DOI: 10.1002/jbmr.1470

Free article

Case Reports

Low bone mass and high material bone density in two patients with Loeys-Dietz syndrome caused by transforming growth factor beta receptor 2 mutations

I Mouna Ben Amor et al. J Bone Miner Res. 2012 Mar.

Free article

Abstract

Loeys-Dietz syndrome (LDS) is a rare autosomal-dominant connective tissue disorder caused by heterozygous mutations in the genes encoding transforming growth factor beta receptor 1 or 2 (TGFBR1 or TGFBR2). Although an association between LDS and osteoporosis has been reported, the skeletal phenotype regarding bone mass is not well characterized. Here, we report on two LDS patients with mutations in TGFBR2. Patient 1 was a 24-year-old man who had a total of three fractures involving the left radius, the left metacarpal, and the right femur. At the age of 14 years, lumbar spine areal bone mineral density Z-score was -4.0 and iliac bone histomorphometry showed elevated bone turnover (bone formation rate per bone surface: 91 µm³/µm²/year; age-matched control values 37 [10], mean [SD]) and mildly low trabecular bone volume per tissue volume (17.2%; age-matched control values 25.7 [5.3]). Bone mineralization density distribution (BMDD) in trabecular bone was increased (Ca(Peak) 22.70 wt% Ca; age-matched control values 21.66 [0.52]). Patient 2, a 17-year-old girl, suffered from diffuse bone pain but had not sustained fractures. At 14 years of age, her lumbar spine areal bone mineral density Z-score was -3.4. Iliac bone histomorphometry at that age confirmed low bone mass (bone volume to tissue volume 10.1%, same control values as above) and high bone turnover (bone formation rate per bone surface 70 µm³/µm²/year). BMDD in trabecular bone was significantly shifted toward increased mineralization (Ca(Peak) 22.36 wt% Ca). Thus, it appears that LDS can be associated with low bone mass and high bone turnover but increased matrix mineralization of trabecular bone.

Similar articles

• Dysregulated TGF-β signaling alters bone microstructure in a mouse model of Loeys-Dietz syndrome.

  Dewan AK, Tomlinson RE, Mitchell S, Goh BC, Yung RM, Kumar S, Tan EW, Faugere MC, Dietz HC 3rd, Clemens TL, Sponseller PD. Dewan AK, et al. J Orthop Res. 2015 Oct;33(10):1447-54. doi: 10.1002/jor.22920. Epub 2015 Jul 14. J Orthop Res. 2015. PMID: 26173585

• Arterial tortuosity and aneurysm in a case of Loeys-Dietz syndrome type IB with a mutation p.R537P in the TGFBR2 gene.

  Kiliç E, Alanay Y, Utine E, Ozgen-Mocan B, Robinson PN, Boduroğlu K. Kiliç E, et al. Turk J Pediatr. 2012 Mar-Apr;54(2):198-202. Turk J Pediatr. 2012. PMID: 22734312

• Multiple facial milia in patients with Loeys-Dietz syndrome.

  Lloyd BM, Braverman AC, Anadkat MJ. Lloyd BM, et al. Arch Dermatol. 2011 Feb;147(2):223-6. doi: 10.1001/archdermatol.2010.284. Epub 2010 Oct 18. Arch Dermatol. 2011. PMID: 20956634

• Arthrogryposis as neonatal presentation of Loeys-Dietz syndrome due to a novel TGFBR2 mutation.

  Valenzuela I, Fernández-Alvarez P, Munell F, Sanchez-Montanez A, Giralt G, Vendrell T, Tizzano EF. Valenzuela I, et al. Eur J Med Genet. 2017 Jun;60(6):303-307. doi: 10.1016/j.ejmg.2017.03.010. Epub 2017 Mar 24. Eur J Med Genet. 2017. PMID: 28344185 Review.

• A new sporadic case of early-onset Loeys-Dietz syndrome due to the recurrent mutation p.R528C in the TGFBR2 gene substantiates interindividual clinical variability.

  Jamsheer A, Henggeler C, Wierzba J, Loeys B, De Paepe A, Stheneur Ch, Badziag N, Matuszewska K, Matyas G, Latos-Bielenska A. Jamsheer A, et al. J Appl Genet. 2009;50(4):405-10. doi: 10.1007/BF03195701. J Appl Genet. 2009. PMID: 19875893 Review.

Cited by

• Orthopaedic Management of Loeys-Dietz Syndrome: A Systematic Review.

  Lynch CP, Patel M, Seeley AH, Seeley MA. Lynch CP, et al. J Am Acad Orthop Surg Glob Res Rev. 2021 Nov 15;5(11):e21.00087. doi: 10.5435/JAAOSGlobal-D-21-00087. J Am Acad Orthop Surg Glob Res Rev. 2021. PMID: 34779796 Free PMC article.

• Loeys-Dietz syndrome: a primer for diagnosis and management.

  MacCarrick G, Black JH 3rd, Bowdin S, El-Hamamsy I, Frischmeyer-Guerrerio PA, Guerrerio AL, Sponseller PD, Loeys B, Dietz HC 3rd. MacCarrick G, et al. Genet Med. 2014 Aug;16(8):576-87. doi: 10.1038/gim.2014.11. Epub 2014 Feb 27. Genet Med. 2014. PMID: 24577266 Free PMC article. Review.

• Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.

  Rhodes SD, Wu X, He Y, Chen S, Yang H, Staser KW, Wang J, Zhang P, Jiang C, Yokota H, Dong R, Peng X, Yang X, Murthy S, Azhar M, Mohammad KS, Xu M, Guise TA, Yang FC. Rhodes SD, et al. J Bone Miner Res. 2013 Dec;28(12):2476-89. doi: 10.1002/jbmr.1992. J Bone Miner Res. 2013. PMID: 23703870 Free PMC article.

• Genetic profiling and cardiovascular phenotypic spectrum in a Chinese cohort of Loeys-Dietz syndrome patients.

  Yang H, Ma Y, Luo M, Zhu G, Zhang Y, Li B, Shu C, Zhou Z. Yang H, et al. Orphanet J Rare Dis. 2020 Jan 8;15(1):6. doi: 10.1186/s13023-019-1282-3. Orphanet J Rare Dis. 2020. PMID: 31915033 Free PMC article.

• Pediatric solid organ transplantation and osteoporosis: a descriptive study on bone histomorphometric findings.

  Tamminen IS, Valta H, Jalanko H, Salminen S, Mäyränpää MK, Isaksson H, Kröger H, Mäkitie O. Tamminen IS, et al. Pediatr Nephrol. 2014 Aug;29(8):1431-40. doi: 10.1007/s00467-014-2771-1. Epub 2014 Feb 23. Pediatr Nephrol. 2014. PMID: 24562785

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems
  • Wiley

• Medical

  • MedlinePlus Health Information